Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline

Int J Tuberc Lung Dis. 2017 Jan 1;21(1):4-5. doi: 10.5588/ijtld.16.0768.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antitubercular Agents / adverse effects
  • Antitubercular Agents / therapeutic use*
  • Diarylquinolines / adverse effects
  • Diarylquinolines / therapeutic use*
  • Drug Resistance, Multiple, Bacterial*
  • Humans
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant / diagnosis
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / epidemiology
  • Tuberculosis, Multidrug-Resistant / microbiology

Substances

  • Antitubercular Agents
  • Diarylquinolines
  • bedaquiline